2023 Q3 Form 10-Q Financial Statement
#000147793223006393 Filed on August 22, 2023
Income Statement
Concept | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | $0.00 | ||
YoY Change | |||
Gross Profit | $0.00 | ||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $294.8K | $240.0K | $245.3K |
YoY Change | 110.87% | 111.38% | -87.31% |
% of Gross Profit | |||
Research & Development | $58.37K | $158.2K | $183.8K |
YoY Change | -79.49% | 209.48% | 118.72% |
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $353.2K | $401.1K | $429.1K |
YoY Change | -16.77% | 143.62% | -78.73% |
Operating Profit | -$353.2K | -$401.1K | -$429.1K |
YoY Change | -16.77% | 143.62% | -78.73% |
Interest Expense | $5.557K | -$10.00K | -$2.050K |
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | -$174.2K | $8.423K | |
YoY Change | |||
Pretax Income | -$179.0K | -$409.6K | -$431.2K |
YoY Change | -57.82% | 148.74% | -78.63% |
Income Tax | $0.00 | $0.00 | $0.00 |
% Of Pretax Income | |||
Net Earnings | -$179.0K | -$403.3K | -$431.2K |
YoY Change | -57.82% | 144.94% | -78.63% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | $0.00 | -$0.01 | -$0.01 |
COMMON SHARES | |||
Basic Shares Outstanding | 40.07M shares | 40.07M shares | 40.07M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $27.54K | $5.860K | $12.37K |
YoY Change | 920.0% | 2984.21% | 406.97% |
Cash & Equivalents | $27.54K | $5.856K | $12.37K |
Short-Term Investments | |||
Other Short-Term Assets | $306.2K | $324.6K | $249.0K |
YoY Change | 5151.63% | 2897.6% | 1473.09% |
Inventory | |||
Prepaid Expenses | $291.0K | $298.3K | $199.3K |
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $333.7K | $330.5K | $261.4K |
YoY Change | 3809.83% | 2898.55% | 1535.94% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | $333.7K | $330.5K | $261.4K |
Total Long-Term Assets | $0.00 | $0.00 | $0.00 |
Total Assets | $333.7K | $330.5K | $261.4K |
YoY Change | 3809.83% | 2898.55% | 1535.94% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.439M | $1.327M | $2.451M |
YoY Change | 254.74% | 751.68% | 1589.27% |
Accrued Expenses | $9.156K | $13.99K | $9.110K |
YoY Change | 9056.0% | 13892.0% | 9010.0% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $50.00K | $100.0K | $50.00K |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $3.149M | $2.983M | $2.511M |
YoY Change | 93.85% | 138.13% | 129.7% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $3.149M | $2.983M | $2.511M |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $3.149M | $2.983M | $2.511M |
YoY Change | 93.85% | 138.13% | 129.7% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$5.958M | -$5.779M | -$5.369M |
YoY Change | 29.96% | 38.91% | 34.38% |
Common Stock | $40.07K | $40.07K | $40.07K |
YoY Change | 2.43% | 2.96% | 2.96% |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$2.815M | -$2.652M | -$2.249M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $333.7K | $330.5K | $261.4K |
YoY Change | 3809.83% | 2898.55% | 1535.94% |
Cashflow Statement
Concept | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$179.0K | -$403.3K | -$431.2K |
YoY Change | -57.82% | 144.94% | -78.63% |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | $52.94K | -$62.76K | -$41.30K |
YoY Change | -211.5% | -142738.64% | -3541.67% |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cash From Investing Activities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -50.00K | $50.00K | 50.00K |
YoY Change | -200.0% | ||
NET CHANGE | |||
Cash From Operating Activities | 52.94K | -$62.76K | -41.30K |
Cash From Investing Activities | 0.000 | $0.00 | 0.000 |
Cash From Financing Activities | -50.00K | $50.00K | 50.00K |
Net Change In Cash | 2.940K | -$6.513K | 8.700K |
YoY Change | 16.67% | -14902.27% | 625.0% |
FREE CASH FLOW | |||
Cash From Operating Activities | $52.94K | -$62.76K | -$41.30K |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q2 | us-gaap |
Assets Current
AssetsCurrent
|
330500 | usd |
CY2023Q2 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001603345 | |
CY2023Q2 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023Q2 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--03-31 | |
CY2023Q2 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2023Q2 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | |
CY2023Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2023Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
40066951 | shares |
CY2023Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
40066951 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
40066951 | shares |
CY2023Q1 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
357102 | shares |
CY2023Q2 | dei |
Document Type
DocumentType
|
10-Q | |
CY2023Q2 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2023Q2 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-06-30 | |
CY2023Q2 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023Q2 | dei |
Entity File Number
EntityFileNumber
|
000-55383 | |
CY2023Q2 | dei |
Entity Registrant Name
EntityRegistrantName
|
AGENTIX CORP. | |
CY2023Q2 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | |
CY2023Q2 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
46-2876282 | |
CY2023Q2 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
32932 Pacific Coast Highway | |
CY2023Q2 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
14-254 | |
CY2023Q2 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Dana Point | |
CY2023Q2 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | |
CY2023Q2 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
92629 | |
CY2023Q2 | dei |
City Area Code
CityAreaCode
|
321 | |
CY2023Q2 | dei |
Local Phone Number
LocalPhoneNumber
|
299-2041 | |
CY2023Q2 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023Q2 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023Q2 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023Q2 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023Q2 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2023Q2 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
40066931 | shares |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
5856 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
12369 | usd |
CY2023Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
324644 | usd |
CY2023Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
249023 | usd |
CY2023Q1 | us-gaap |
Assets Current
AssetsCurrent
|
261392 | usd |
CY2023Q2 | us-gaap |
Assets
Assets
|
330500 | usd |
CY2023Q1 | us-gaap |
Assets
Assets
|
261392 | usd |
CY2023Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1327212 | usd |
CY2023Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1057215 | usd |
CY2023Q2 | agtx |
Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
|
1541769 | usd |
CY2023Q1 | agtx |
Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
|
1394230 | usd |
CY2023Q2 | agtx |
Notes Payable Related Party Current And Noncurrent
NotesPayableRelatedPartyCurrentAndNoncurrent
|
100000 | usd |
CY2023Q1 | agtx |
Notes Payable Related Party Current And Noncurrent
NotesPayableRelatedPartyCurrentAndNoncurrent
|
50000 | usd |
CY2023Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
13992 | usd |
CY2023Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
9110 | usd |
CY2023Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2982973 | usd |
CY2023Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2510555 | usd |
CY2023Q2 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
0 | usd |
CY2023Q1 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
0 | usd |
CY2023Q2 | us-gaap |
Liabilities
Liabilities
|
2982973 | usd |
CY2023Q1 | us-gaap |
Liabilities
Liabilities
|
2510555 | usd |
CY2023Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
0 | usd |
CY2023Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
0 | usd |
CY2023Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
40067 | usd |
CY2023Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
40067 | usd |
CY2023Q2 | us-gaap |
Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
|
53535 | usd |
CY2023Q1 | us-gaap |
Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
|
53535 | usd |
CY2023Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
3025796 | usd |
CY2023Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
3025796 | usd |
CY2023Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
|
7013 | usd |
CY2023Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
|
765 | usd |
CY2023Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-5778884 | usd |
CY2023Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-5369326 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2652473 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2249163 | usd |
CY2023Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
330500 | usd |
CY2023Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
261392 | usd |
CY2023Q2 | us-gaap |
Professional Fees
ProfessionalFees
|
115126 | usd |
CY2022Q2 | us-gaap |
Professional Fees
ProfessionalFees
|
88844 | usd |
CY2023Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
158182 | usd |
CY2022Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
51112 | usd |
CY2023Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
127827 | usd |
CY2022Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
24698 | usd |
CY2023Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
401135 | usd |
CY2022Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
164654 | usd |
CY2023Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-401135 | usd |
CY2022Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-164654 | usd |
CY2023Q2 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-3343 | usd |
CY2022Q2 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
0 | usd |
CY2023Q2 | us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
5080 | usd |
CY2022Q2 | us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
0 | usd |
CY2023Q2 | us-gaap |
Other Expenses
OtherExpenses
|
8423 | usd |
CY2022Q2 | us-gaap |
Other Expenses
OtherExpenses
|
0 | usd |
CY2023Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-409558 | usd |
CY2022Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-164654 | usd |
CY2023Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
CY2022Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
CY2023Q2 | us-gaap |
Profit Loss
ProfitLoss
|
-409558 | usd |
CY2022Q2 | us-gaap |
Profit Loss
ProfitLoss
|
-164654 | usd |
CY2023Q2 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
6248 | usd |
CY2022Q2 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
0 | usd |
CY2023Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-403310 | usd |
CY2022Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-164654 | usd |
CY2023Q2 | agtx |
Loss Per Share Basic And Diluted
LossPerShareBasicAndDiluted
|
-0.01 | |
CY2022Q2 | agtx |
Loss Per Share Basic And Diluted
LossPerShareBasicAndDiluted
|
-0.00 | |
CY2023Q2 | agtx |
Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
|
40066951 | shares |
CY2022Q2 | agtx |
Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
|
38916951 | shares |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-403310 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2652473 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1076998 | usd |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-164654 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1241652 | usd |
CY2023Q2 | us-gaap |
Profit Loss
ProfitLoss
|
-409558 | usd |
CY2022Q2 | us-gaap |
Profit Loss
ProfitLoss
|
-164654 | usd |
CY2023Q2 | agtx |
Amortization Of Stock Issued For Software
AmortizationOfStockIssuedForSoftware
|
-7894 | usd |
CY2022Q2 | agtx |
Amortization Of Stock Issued For Software
AmortizationOfStockIssuedForSoftware
|
-5000 | usd |
CY2023Q2 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
83515 | usd |
CY2022Q2 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
0 | usd |
CY2023Q2 | us-gaap |
Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
|
422418 | usd |
CY2022Q2 | us-gaap |
Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
|
159698 | usd |
CY2023Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-62761 | usd |
CY2022Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
44 | usd |
CY2023Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd |
CY2022Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd |
CY2023Q2 | us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
50000 | usd |
CY2022Q2 | us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
0 | usd |
CY2023Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
50000 | usd |
CY2022Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
0 | usd |
CY2023Q2 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
6248 | usd |
CY2022Q2 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
0 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-6513 | usd |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
44 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
12369 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
145 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
5856 | usd |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
189 | usd |
CY2023Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2023Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
40066951 | shares |